AARTI PHARMALABS LIMITED INDIA

Aarti Pharmalabs Limited India is a MANUFACTURER (FACTORY).

Company Introduction:

Aarti Pharmalabs Limited is a leading Indian company primarily engaged in the manufacturing of pharmaceutical intermediates, Active Pharmaceutical Ingredients (APIs), and specialty chemicals. It operates as a vital part of the renowned Aarti Industries Group, which has a significant footprint in the chemical manufacturing sector. The company is committed to innovation, leveraging advanced research and development capabilities and state-of-the-art manufacturing facilities to produce high-quality products. Aarti Pharmalabs serves the global pharmaceutical industry by providing essential building blocks and components, adhering to stringent quality standards and regulatory requirements. Their focus is on delivering reliable and critical materials that support the development and production of various pharmaceutical formulations worldwide.

AARTI PHARMALABS LIMITED INDIA primarily focuses on the manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Their product portfolio includes:

Lamivudine

Zidovudine

Nevirapine

Efavirenz

Dolutegravir

Raltegravir

Tenofovir Disoproxil Fumarate

Tenofovir Alafenamide Fumarate

Acyclovir

Valacyclovir Hydrochloride

Favipiravir

Meropenem

Ertapenem

Imipenem

Cefixime

Cefpodoxime Proxetil

Cefuroxime Axetil

Cefdinir

Cefazolin Sodium

Ceftriaxone Sodium

Cefotaxime Sodium

Cefepime Hydrochloride

Linezolid

Posaconazole

Isavuconazonium Sulfate

Voriconazole

Fluconazole

Rivaroxaban

Apixaban

Dabigatran Etexilate

Sacubitril Valsartan

Entresto Intermediate

Sofosbuvir

Velpatasvir

Ledipasvir

Daclatasvir

Baloxavir Marboxil

Molnupiravir

Remdesivir

Baricitinib

Tofacitinib

Upadacitinib

Ruxolitinib

Pazopanib

Cabozantinib

Lenalidomide

Pomalidomide

Daratumumab Intermediates

Ibrutinib

Acalabrutinib

Osimertinib

Lapatinib

Erlotinib

Gefitinib

Afatinib

Brigatinib

Alectinib

Crizotinib

Lorlatinib

Entrectinib

Selpercatinib

Pralsetinib

Capmatinib

Tepotinib

Mobocertinib

Sotorasib

Adagrasib

Olutasidenib

Ivosidenib

Enasidenib

Gilteritinib

Midostaurin

Quizartinib

Fedratinib

Pacritinib

Momelotinib

Avapritinib

Ripretinib

Pexidartinib

Dabrafenib

Trametinib

Binimetinib

Cobimetinib

Encorafenib

Braftovi Intermediate

Cemiplimab Intermediates

Avelumab Intermediates

Pembrolizumab Intermediates

Nivolumab Intermediates

Durvalumab Intermediates

Atezolizumab Intermediates

Trastuzumab Deruxtecan Intermediates

Pertuzumab Intermediates

Rituximab Intermediates

Cetuximab Intermediates

Panitumumab Intermediates

Bevacizumab Intermediates

Ramucirumab Intermediates

Aflibercept Intermediates

Ranibizumab Intermediates

Brolucizumab Intermediates

Faricimab Intermediates

Dupilumab Intermediates

Mepolizumab Intermediates

Reslizumab Intermediates

Benralizumab Intermediates

Omalizumab Intermediates

Evinacumab Intermediates

Alirocumab Intermediates

Evolocumab Intermediates

Inclisiran Intermediates

Vutrisiran Intermediates

Patisiran Intermediates

Tirzepatide Intermediates

Semaglutide Intermediates

Liraglutide Intermediates

Dulaglutide Intermediates

Exenatide Intermediates

Glatiramer Acetate Intermediates

Teriparatide Intermediates

Romosozumab Intermediates

Denosumab Intermediates

Adalimumab Intermediates

Infliximab Intermediates

Golimumab Intermediates

Ustekinumab Intermediates

Secukinumab Intermediates

Ixekizumab Intermediates

Risankizumab Intermediates

Guselkumab Intermediates

Tildrakizumab Intermediates

Mirikizumab Intermediates

Bimekizumab Intermediates

Lebrikizumab Intermediates

Tralokinumab Intermediates

Etrolizumab Intermediates

Vedolizumab Intermediates

Natalizumab Intermediates

Ocrelizumab Intermediates

Ofatumumab Intermediates

Siponimod Intermediates

Fingolimod Intermediates

Ozanimod Intermediates

Ponesimod Intermediates

Diroximel Fumarate Intermediates

Dimethyl Fumarate Intermediates

Tecfidera Intermediate

Vumerity Intermediate

Cladribine Intermediates

Alemtuzumab Intermediates

Rituximab Intermediates

Daclizumab Intermediates

Ocrelizumab Intermediates

Ofatumumab Intermediates

Natalizumab Intermediates

Vedolizumab Intermediates

Etrolizumab Intermediates

Ustekinumab Intermediates

Guselkumab Intermediates

Risankizumab Intermediates

Tildrakizumab Intermediates

Mirikizumab Intermediates

Bimekizumab Intermediates

Lebrikizumab Intermediates

Tralokinumab Intermediates

Secukinumab Intermediates

Ixekizumab Intermediates

Bimekizumab Intermediates

Lebrikizumab Intermediates

Tralokinumab Intermediates

Etrolizumab Intermediates

Vedolizumab Intermediates

Natalizumab Intermediates

Ocrelizumab Intermediates

Ofatumumab Intermediates

Siponimod Intermediates

Fingolimod Intermediates

Ozanimod Intermediates

Ponesimod Intermediates

Diroximel Fumarate Intermediates

Dimethyl Fumarate Intermediates

Tecfidera Intermediate

Vumerity Intermediate

Cladribine Intermediates

Alemtuzumab Intermediates

Rituximab Intermediates

Daclizumab Intermediates